Gašper Berginc

Sixteen novel mutations identified in COL4A3, COL4A4, and COL4A5 genes in Slovenian families with Alport syndrome and benign familial hematuria

Maja Šlajpah, B. Gorinšek, Gašper Berginc et al. · Kidney International · 2007 · 80 citations · Full text

Mendelian Disorder, Genetic Disorder, Genetics +10

Presence of activating KRAS mutations correlates significantly with expression of tumour suppressor genes DCN and TPM1 in colorectal cancer

Vid Mlakar, Gašper Berginc, Metka Volavšek et al. · BMC Cancer · 2009 · 49 citations · Full text

Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome

Gašper Berginc, Matej Bračko, Metka Ravnik‐Glavač et al. · Familial Cancer · 2009 · 28 citations

Pms2 Genes, Oncology, Somatic Variant +11

Rapid and accurate approach for screening of microsatellite unstable tumours using quasimonomorphic mononucleotide repeats and denaturating high performance liquid chromatography (DHPLC).

Gašper Berginc, Damjan Glavač · Europe PMC (PubMed Central) · 2009 · 10 citations · Full text

Genetic Testing, Genetics, Msi Analysis Approach +20